Canine prostatic carcinoma

Compendium: Continuing Education For Veterinarians

Volumn 34, Issue 10, 2012, Pages

  Axiak, Sandra M ^a   Bigio, Astrid ^b  

^a UNIVERSITY OF MISSOURI   (United States)

^b LOUISIANA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84869186104     PISSN: 19408307     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Bryan JN, Keeler MR, Henry CJ, et al. A population study of neutering as a risk factor for canine prostate cancer. Prostate 2007;67:1174-1181.
2. LeRoy BE, Northrup N. Prostate cancer in dogs: comparative and clinical aspects. Vet J 2009;180:149-162.
3. Bell FW, Klausner JS, Hayden DW, et al. Clinical and pathologic features of prostatic adenocarcinoma in sexually intact and castrated dogs: 31 cases (1970-1987). J Am Vet Med Assoc 1991;199(11):1623-1630.
4. Cornell KK, Bostwick DG, Cooley DM. Clinical and pathologic aspects of spontaneous canine prostate carcinoma: a retrospective analysis of 76 cases. Prostate 2000;45:173-183.
5. Teske E, Naan EC, vanDijk EM, et al. Canine prostate carcinoma: epidemiological evidence of an increased risk in castrated dogs. Mol Cell Endocrinol2002;197:251-255.
6. Obradovich J, Walshaw R, Goullaud E. The inluence of castration on the development of prostatic carcinoma in the dog. J Vet tern Med 1987;1:183-187.
7. Smith J. Canine prostatic disease: a review of anatomy, pathology, diagnosis, and treatment. Theriogenology2008;70:375-383.
8. Bradbury CA, Westropp JL, Pollard RE. Relationship between prostatomegaly prostatic mineralization, and cytologic diagnosis. Vet Radiol Ultrasound 2009;50(2):167-171.
9. Nemanic S, London CA, Wisner ER. Comparison of thoracic radiographs and single breath-hold helical CT for detection of pulmonary nodules in dogs with metastatic neoplasia. J Vet Intern Med 2006;20:508-515.
10. Vignoli M, Rossi F, Chierici C, et al. Needle tract implantation after ine needle aspiration biopsy (FNAB) of transitional cell carcinoma of the urinary bladder and adenocarcinoma of the lung. Schweiz Arch Tierheilkd 2007;149(7):314-318.
11. Powe JR, Canield PJ, Martin PA. Evaluation of the cytologic diagnosis of canine prostatic disorders. Vet Clin Pathol 2004;33(3):150-154.
12. Basinger RR, Rawlings CA, Barsanti JA, et al. Urodynamic alterations associated with clinical prostatic diseases and prostatic surgery in 23 dogs. J Am Anim Hosp Assoc 1989;25:385-392.
13. Hardie EM, Barsanti JA, Rawlings CA. Complications of prostatic surgery. J Am Anim Hosp Assoc 1984;20:50-56.
14. Vlasin M, Rauser P, Fichtel T, et al. Subtotal intracapsular prostatectomy as a useful treatment for advanced stage prostatic malignancies. J Small Anim Pract 2006;47:512-516.
15. L'Eplattenier HF, van Nimwegen SA, van Sluijs FJ, et al. Partial prostatectomy using Nd:YAG laser for management of canine prostate carcinoma. Vet Surg 2006;35:406-411.
16. L'Eplattenier HF, Klem B, Teske E, et al. Preliminary results of intraoperative photo-dynamic therapy with 5-aminolevulinic acid in dogs with prostate carcinoma. Vet J 2008; 178:202-207.
17. Lucroy MD, Bowles MH, Higbee RG, et al. Photodynamic therapy for prostatic carcinoma in a dog. J Vet Intern Med 2003;17:235-237.
18. Liptak JM, Brutscher SP, Monnet E, et al. Transurethral resection in the management of urethral and prostatic neoplasia in 6 dogs. Vet Surg2004;33:505-516.
19. Weisse C, Berent A, Todd K, et al. Evaluation of palliative stenting for management of malignant urethral obstructions in dogs. J Am Vet Med Assoc2006;229(2):226-234.
20. Turrel JM. Intraoperative radiotherapy of carcinoma of the prostate gland in ten dogs. J Am Vet Med Assoc 1987;190(1):48-52.
21. Anderson CR, McNiel EA, Gillette EL, et al. Late complications of pelvic irradiation in 16 dogs. Vet Radiol Ultrasound 2002;43(2):187-192.
22. Sorenmo KU, Goldschmidt MH, Shofer FS, et al. Evaluation of cyclooxygenase-1 and cyclooxygenase-2 expression and the effect of cyclooxygenase inhibitors in canine prostate carcinoma. Vet Comp Oncol 2004;2(1):13-21.
23. Osoba D, Tannock IF, Ernst DS, et al. Health related quality of life in men with metastatic prostate cancer treated with prednisone alone or mitoxantrone and prednisone. J Clin Oncol 1999;17(6):1654-1663.
24. Fan TM, de Lorimer LP, Charney SC, et al. Evaluation of intravenous pamidronate administration in 33 cancer-bearing dogs with primary or secondary bone involvement. J Vet Intern Med 2005;19:74-80.
25. Barnard SM, Zuber RM, Moore AS. Samarium Sm 153 lexidronam for the palliative treatment of dogs with primary bone tumors: 35 cases (1999-2005). J Am Vet Med Assoc 2007;230(12):1877-1881.